Stocks and Investing Stocks and Investing
Fri, October 29, 2021
Thu, October 28, 2021

Brian Abrahams Initiated (XENE) at Buy and Held Target at $43 on, Oct 28th, 2021


Published on 2024-10-27 18:23:27 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $43 on, Oct 28th, 2021.

Brian has made no other calls on XENE in the last 4 months.



There is 1 other peer that has a rating on XENE. Out of the 1 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.



This is the rating of the analyst that currently disagrees with Brian


  • Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $48 on, Monday, October 4th, 2021
Contributing Sources